Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-1).

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

December 1, 2018

Study Completion Date

December 31, 2018

Conditions
Type 1 Diabetes Mellitus
Interventions
BIOLOGICAL

Influenza vaccination

"Correct influenza vaccination status was considered in the following situation:~\- Received at least one Influenza vaccine dose in the last year."

BIOLOGICAL

Pneumococcal vaccination

"Correct pneumococal vaccination status was considered if a subject received at least one of the following options:~* One pneumococcal conjugate vaccine (PCV) 13 dose in the last year.~* One PCV13 dose following a pneumococcal polysaccharide vaccine (PPSV) 23 dose between the following 8 weeks and 12 months.~* One PPSV 23 dose in the last 5 years.~* One PPSV23 dose in the last 5 years and a second PPSV23 dose at 5 years or PCV13 at 1 year."

BIOLOGICAL

Hepatitis B Virus (HBV) vaccination

"Correct Hepatitis B Virus (HBV) vaccination status was considered in the following situation:~.- Received at least three consecutive doses of HBV vaccine during six consecutive months."

Trial Locations (1)

13005

Obispo Rafael Torija, St., Ciudad Real

All Listed Sponsors
collaborator

Castilla-La Mancha Health Service

OTHER

collaborator

University of Castilla-La Mancha

OTHER

lead

Jesús Moreno Fernández

OTHER

NCT03478254 - Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-1). | Biotech Hunter | Biotech Hunter